BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 22062588)

  • 21. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.
    Cesena FH; Dimayuga PC; Yano J; Zhao X; Kirzner J; Zhou J; Chan LF; Lio WM; Cercek B; Shah PK; Chyu KY
    Atherosclerosis; 2012 Jan; 220(1):59-65. PubMed ID: 22062590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
    Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional role for inducible costimulator (ICOS) in atherosclerosis.
    Afek A; Harats D; Roth A; Keren G; George J
    Atherosclerosis; 2005 Nov; 183(1):57-63. PubMed ID: 15941568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis.
    Engelbertsen D; Foks AC; Alberts-Grill N; Kuperwaser F; Chen T; Lederer JA; Jarolim P; Grabie N; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2526-35. PubMed ID: 26494229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice.
    Macritchie N; Grassia G; Sabir SR; Maddaluno M; Welsh P; Sattar N; Ialenti A; Kurowska-Stolarska M; McInnes IB; Brewer JM; Garside P; Maffia P
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2569-79. PubMed ID: 22936340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
    Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E
    Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
    Wan Q; Liu Z; Yang M; Wu J
    Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
    Mueller PA; Kojima Y; Huynh KT; Maldonado RA; Ye J; Tavori H; Pamir N; Leeper NJ; Fazio S
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e1-e9. PubMed ID: 34758632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.
    Rattik S; Mantani PT; Yao Mattisson I; Ljungcrantz I; Sundius L; Björkbacka H; Terrinoni M; Lebens M; Holmgren J; Nilsson J; Wigren M; Nordin Fredrikson G
    Vascul Pharmacol; 2018 Dec; 111():54-61. PubMed ID: 30243560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A; Gustafsson R; Kalamajski S; Krams R; Segers D; Rauch U; Roos G; Nilsson J; Oldberg Å; Hultgårdh-Nilsson A
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):354-61. PubMed ID: 23202368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in CD4
    Xue-Mei L; Jie C; Xuan D; Xiao-Xing L; Chun-Lin H; Yu-Jie L
    Exp Biol Med (Maywood); 2017 May; 242(9):918-925. PubMed ID: 28114815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.
    Hosseini H; Yi L; Kanellakis P; Cao A; Tay C; Peter K; Bobik A; Toh BH; Kyaw T
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuated atherogenesis in apolipoprotein E-deficient mice lacking amyloid precursor protein.
    Van De Parre TJ; Guns PJ; Fransen P; Martinet W; Bult H; Herman AG; De Meyer GR
    Atherosclerosis; 2011 May; 216(1):54-8. PubMed ID: 21316678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
    Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.
    Deshpande V; Krishnan R; Philip S; Faludi I; Ponnusamy T; Thota LN; Endresz V; Lu X; Kakkar VV; Mundkur LA
    Cardiovasc Ther; 2016 Oct; 34(5):314-24. PubMed ID: 27241889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis.
    Jones GW; McLeod L; Kennedy CL; Bozinovski S; Najdovska M; Jenkins BJ
    Atherosclerosis; 2015 Feb; 238(2):321-8. PubMed ID: 25545330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.